TrialThe Lancet. Infectious diseases2026

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.

Deborah R Leitner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.